Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [18F]AmBF3-TATE.
Joseph LauJinhe PanEtienne RousseauCarlos F UribeSudhakara Reddy SeelamBrent W SutherlandDavid M PerrinKuo-Shyan LinFrançois BénardPublished in: EJNMMI research (2020)
[18F]AmBF3-TATE binds specifically to SSTR2. At 1000× clinical dose, [19F]AmBF3-TATE was well tolerated with no treatment-related adverse effects.